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In a typical shotgun proteomics experiment, a significant number of high-quality MS/MS
spectra remain ‘‘unassigned.’’ The main focus of this work is to improve our understanding
of various sources of unassigned high-quality spectra. To achieve this, we designed an
iterative computational approach for more efficient interrogation of MS/MS data. The
method involves multiple stages of database searching with different search parameters,
spectral library searching, blind searching for modified peptides, and genomic database
searching. The method is applied to a large publicly available shotgun proteomic data set.
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A typical shotgun proteomic experiment involves generation
of thousands of tandem mass spectra. The development of
computational tools has made automatic identification of
peptides from these spectra a routine approach. Continuous
efforts are made to improve the sensitivity and specificity of
peptide identification methods, and methods to estimate the
error rates in the resulting data sets [1, 2]. However, despite
improvements in MS instrumentation and peptide identifi-
cation algorithms, a significant number of MS/MS spectra
in any large-scale study remain ‘‘unassigned’’ (i.e. no high
confidence peptide identification) [3]. A significant fraction
of these spectra are of high quality, as measured using
various spectral features [4–6], and additional studies are
necessary to gain a better understanding of their nature and
significance.
Peptides are most often identified from MS/MS spectra
using sequence database searching, either in a direct fash-
ion [7–9] or with the aid of sequence tags [10–12]. High-
quality spectra may remain unidentified in a typical data
analysis pipeline due to several reasons: inaccurate charge
state or precursor ion m/z measurement, constrained data-
base search parameters (e.g. search for tryptic peptides only),
the presence of chemical modifications or PTMs, and
incompleteness of the searched protein sequence database
[3, 13, 14]. The last two categories, peptides containing
PTMs and novel peptides, are particularly interesting. Such
peptides can be identified using de novo sequencing, error-
tolerant (or ‘‘blind’’) database search [15], and by searching
against genomic databases such as translated EST databases
[16, 17]. However, these methods are not commonly applied
as primary peptide identification methods because they are
more time consuming and error prone than conventional
database searching.
This study extends our previous analysis of the unas-
signed high-quality spectra [3]. We implement and
apply a more comprehensive and efficient computational
strategy based on iterative analysis of MS/MS data
using a combination of several existing computational
tools. The analysis, outlined in Fig. 1, involves the use of
spectral library searching [18, 19], blind searching for PTM
analysis, and genomic database searching. The iterative
nature in which these different approaches are applied to
data allows increasing the number of assigned MS/MS
spectra without a substantial increase in the computational
time.
Abbreviations: FDR, false discovery rate; NCBI NR, NCBI non-
redundant; SNP, single nucleotide polymorphism; SQS, spectral
quality score; WCL, whole-cell lysates
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The method is applied to a large publicly available data
set of MS/MS spectra from the Human T leukemic cells
[20]. Briefly, the whole-cell lysates (WCL) were separated by
one-dimensional gel electrophoresis and the gel lanes were
cut into 18 gel slices. The proteins contained in the gel slices
were digested with trypsin, and the peptides were extracted
and analyzed by LC-MS/MS using an LTQ ion trap mass
spectrometer. The data set contains 14 replicate analyses of
the WCL, which was used here as the primary data set.
Additional analysis was performed using two subcellular
fractions: the plasma membrane and the lipid raft.
The protein sequence databases used in this work
included the Human International Protein Index (IPI)
database v3.32 containing 67 575 entries [21], the NCBI non-
redundant (NR) Human database containing 383 745 entries
(downloaded on 02/15/2008), and the translated genomic
database, compiled from multiple sources and compressed
for computational efficiency as described in [17] (down-
loaded on 01/02/2008 from ftp://ftp.umiacs.umd.edu/pub/
nedwards/PepSeqDB).
In the initial analysis, the spectra were searched with X!
TANDEM/k-score [22] against the Human IPI database
described above appended with an equal number of reversed
protein sequences as decoys [21]. The search parameters
were as follows: parent ion mass tolerance window of 2.0
to 2.0 Da, 0.8 Da monoisotopic fragment ion mass tolerance,
tryptic peptides only. Two variable modifications were
considered: methionine oxidation and N-terminal acetyla-
tion. The refinement mode was not used. PeptideProphet
[23] was then used to calculate the probability for each of the
spectrum assignments. The spectra with QualScore [3]
spectral quality score (SQS) above 1.0 were considered high-
quality spectra. The spectra with PeptideProphet probability
below 0.1 and SQS score above 1.0 were considered unas-
signed high-quality spectra. These spectra, representing
approximately 10% of the full MS/MS data set, were the
main focus of this work. We also note that among the
unassigned spectra of lower quality, which were not further
interrogated here, many are likely to represent valid
peptides. Peptides that fall into the non-mobile proton
model category, or contain extra liable bonds, are known to
fragment poorly in conventional MS strategies [24], and
their analysis requires the use of more sophisticated peptide
fragmentation models [25, 26] than what is implemented in
most currently available database search tools.
Unassigned high-quality spectra were reanalyzed using
several additional steps: X! TANDEM database searching
against the subset database containing sequences
of proteins identified with high ProteinProphet probabili-
ties (greater than or equal to 0.9) [27] in the initial
search (to identify additional tryptic peptides by searching
against a smaller database compared to the original search,
as well as semi-tryptic peptides, and peptides with inaccu-
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Figure 1. Overview of the
iterative peptide identification
strategy. Proteins are digested
into peptides, and peptides are
sequenced using MS/MS.
Acquired spectra are analyzed
using conventional database
searching. Peptide identifica-
tions are processed using
PeptideProphet and Protein-
Prophet. A spectral quality
assessment tool is used to
select unassigned high-quality
spectra. These spectra are
reanalyzed using X! TANDEM
and InsPecT (normal and blind
mode) against the subset
protein database, and using
SpectraST spectral library
search tool. The remaining
unassigned spectra are sear-
ched against the translated
genomic database to identify
novel peptides and peptide
polymorphisms.
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blind InsPecT searching (extensive PTM analysis to
identify the most common modifications, step ii); normal
InsPecT with an extended set of modifications (for better
identification of most frequent modifications discovered
using the blind search, step iii); spectral library searching
using SpectraST [18] (more sensitive scoring method,
as compared to conventional database searching, for
assigning MS/MS spectra produced by previously identified
peptides [28, 29], step iv); genomic database searching
(for identification of peptides not present in the protein
sequence database used in the initial search and in steps
i–iv, see step v). These steps are described below in more
detail (see Fig. 1):
(i) X! TANDEM search (without refinement), subset
database, larger (than initial search) parent ion mass
tolerance of 4.0 Da, allowing semi-tryptic peptides. The
same modifications were considered as in the initial
search, i.e. methionine oxidation and N-terminal
acetylation.
(ii) InsPecT blind mode search, subset database, 2.5 Da
parent ion mass tolerance, and allowing tryptic
peptides only. In the blind mode, InsPecT attempts to
identify peptides with unexpected PTMs or chemical
modifications by allowing unrestricted (any mass shift)
modification of any one residue in the peptide
sequence.
(iii) InsPecT normal mode, subset database, 2.5 Da parent
ion mass tolerance, and allowing semi-tryptic peptides.
The most frequent modifications based on the InsPecT
blind mode analysis (step ii) were specified as variable
modifications (see below).
(iv) SpectraST search with default settings against a
spectral library generated by combining the NIST
Human MS/MS library (v. 2006-12-13) and the experi-
ment-specific library generated from the spectra
identified in the initial X! TANDEM search [30].
(v) The high-quality spectra that remained unassigned
after steps i–iv above were searched against the
translated Human genomic database with X! TANDEM
(3.0 Da parent ion mass tolerance, tryptic peptide only,
without refinement) and InsPecT (2.5 Da parent ion
mass tolerance, tryptic peptides only) for novel peptide
identifications. Only methionine oxidation was allowed
as a variable modification in both searches.
To estimate the false discovery rate (FDR) [1] at each step
in the process, an equal number of decoy protein sequences
(reversed sequences) were appended to the searched data-
base. In the case of the translated genomic database search,
due to its large size, the number of appended decoy
sequences was a fourth of the database size. A non-para-
metric probability mixture model [31] was applied to X!
TANDEM and InsPecT genomic database search results.
This model does not require that the target and decoy
database to be of equal size. The filtering thresholds were
selected to achieve the FDR of less than 0.05. It should be
noted that the validity of the FDR estimates in the case of
iterative database searches has yet to be carefully investi-
gated. However, because the focus of this study is on
exploring general trends and understanding the sources of
unassigned high-quality spectra, the results presented below
should not be significantly affected by the details of FDR
analysis and data filtering performed at each step.
The distributions of SQS for all of the spectra, and
separately for assigned and unassigned spectra (after the
initial search), were analyzed (Fig. 2A). The quality score of
1.0 was found to separate assigned and unassigned spectra
fairly well. Of all spectra in the data set, over 65% were










































Figure 2. Prevalence and categories of unassigned high-quality
spectra. (A) The distribution of spectral quality scores plotted for
all spectra (solid line), and separately for unassigned (dash dot
line) and assigned (short dash) spectra after the initial database
search. (B) The ratio of spectra assigned to peptides of different
types (‘‘percent total’’ refers to the proportion of spectra
assigned to peptides of different type among the total number of
initially unassigned spectra) during reanalysis, plotted as a
function of the spectral quality score. The category ‘‘tryptic,
subset db’’ refers to spectra corresponding to unmodified tryptic
peptides that were identified due to reduced search space. The
category ‘‘tryptic, spectral lib’’ refers to spectra corresponding to
unmodified tryptic peptides identified using spectral library
searching, and it includes some spectra that were also identified
by other methods. WCL fraction data.
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unassigned low-quality spectra (SQSo1, probability below
0.1), and close to 10% of spectra were of high quality
(SQS41) and unassigned. A significant proportion of these
unassigned high-quality spectra (more than 30%) could be
assigned at one of the reanalysis steps described above.
Figure 2B shows the distribution of spectra as a function of
SQS identified at steps i–iv of the reanalysis pipeline and
grouped into different categories. Several trends are appar-
ent. The ratio of spectrum assignments (fraction of assigned
spectra among all initially unassigned spectra) obtained via
spectrum library searching decreases with increasing SQS
scores. This indicates that spectral library searching is most
advantageous (for gaining additional identifications) when
applied to spectra of lower quality. Thus, in those applica-
tions where the primary goal is to increase the number of
spectral assignments, spectral library searching should be
applied on the entire data set, i.e. without spectral quality
filtering. It was also found that a significant number of
spectra were due to semi-tryptic peptides (more than 5% of
the total number of assigned spectra, including peptides
identified in the initial search). The other two main cate-
gories were modified tryptic peptides and tryptic peptides
with incorrectly measured parent ion m/z value. A small
number of tryptic peptides were identified due to reduced
database size (subset database). These peptides were masked
in the original search by other peptides (‘‘distraction effect’’
[32]).
The initial search included two modifications only:
methionine oxidation and N-terminal acetylation (or carba-
mylation, as it cannot be distinguished from acetylation in
low mass accuracy data sets). A much larger space of PTMs
and chemical modifications was explored using the blind
mode of InsPecT, which allows any mass shift on any one
residue in the peptide sequence. The blind search revealed a
large number of frequent modifications (the most frequent
ones are listed in Fig. 3). However, we also found that while
the blind mode of InsPecT was successful at identifying the
most frequent types of modifications in this data set, it was
not as sensitive at detecting any particular type of modifi-
cation as the normal mode InsPecT with that modification
explicitly specified in the input file as a variable modifica-
tion. Furthermore, blind mode InsPecT had a difficulty with
localizing the site of the modification (e.g. in the case of
phosphorylation, in some instances the 180 Da shift was
placed on a residue other than S, T, or Y). Due to these
concerns, and acknowledging the difficulty of accurate FDR
control in the case of blind searches, we have not counted
spectral assignments identified by the blind InsPecT search
only. Instead, the blind mode was used for identifying the
most frequent modifications in the data set, which was
followed by the normal InsPecT search allowing these most
frequent modifications only (see Fig. 1).
A more detailed analysis of modified peptides revealed
several interesting trends. The higher the protein abun-
dance (measured using spectral counts [1]), the more likely
it was to observe a modified peptide from that protein
(Fig. 3A), in agreement with previous observations [3, 14].
The rate of modifications across different samples was






























































































































































Figure 3. Additional analysis of peptide categories. (A) The ratio
of proteins (among proteins of similar abundance as measured
using spectral counts) containing at least one modified peptide
of a particular type (WCL fraction data). Shown are methionine
oxidation (116), N-terminal acetylation/carbamylation (142),
and pyroglutamic acid formation from N-terminal glutamic acid
(17.0). (B) Most frequent modifications and their normalized
frequencies in WCL, plasma membrane (PM), and raft fractions.
(C) Novel peptides (according to NCBI NR database) identified by
the genomic database search and categorized by edit distance
(WCL, plasma membrane, and raft fractions).
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of the most frequent modifications in WCL, as well as in
plasma membrane and raft fractions. While the overall
trend is the same (e.g. oxidation was the most common
modification), there are noticeable differences, likely
reflecting variations in sample handling. It is also apparent
that the dominant majority of identified modifications are
chemical modifications likely due to sample handling, and
not biologically relevant modifications.
Many high-quality spectra (more than 50% of all initially
unassigned high-quality spectra) remained unassigned after
all reanalysis steps involving searches against protein
sequence databases. A small fraction (o10%) of these still
unassigned spectra were identified by performing X!
TANDEM and InsPecT searches against the translated
genomic database, followed by a non-parametric target-
decoy based FDR control [31] to achieve less than 5% FDR.
The peptides found by genomic database searching were
mapped to protein sequences in the NCBI NR database. For
each peptide, the edit distance was computed between the
peptide and its closest match (smallest edit distance) in
the NCBI NR databases. Edit distance is defined here as the
number of amino acid differences between the two peptides.
Peptides with non-zero edit distance were referred to as
‘‘novel’’ peptides. Figure 3C shows the distribution of novel
peptides in terms of the edit distance. While many of the
novel peptides differed from the best matching NCBI NR
peptide by edit distance of 1 (putative single nucleotide
polymorphisms, SNPs), a substantial proportion had high
edit distances (putative novel splice variants). A more
detailed analysis was then performed by searching the
sequences of novel peptides against the human dbSNP
database [33]. Results show that only about 5% of peptide
polymorphisms found in this data set corresponded to
known SNPs in dbSNP. Furthermore, a number of possible
alternative splice variants were discovered from alignment
of novel peptides against the gene models in UCSC genome
browser by BLAT [34]. As a part of this technical report,
however, no attempt was made to further validate any of the
specific identifications.
Efficiency of the computational analysis is an important
practical consideration. All work was done on a Linux server
with a 2.2 GHz CPU and 16 GB of memory. An average
mzXML file took 1 h (per CPU) for the initial search using X!
TANDEM. The blind InsPecT search was performed against
the subset database (a fraction of the original database size),
and the searches against the genomic database were
manageable due to the database compression [17]. Limiting
the reanalysis to unassigned high-quality spectra only was
also important since these spectra represented a small
fraction of the original data set. The time to build and search
the spectral library was not significant compared to various
sequence database search steps. Overall, the reanalysis of
spectra took less than 1 h (per CPU/mzXML file) for X!
TANDEM, InsPecT (normal mode) and SpectraST searches
combined, less than 2 h for InsPecT blind mode, and 2–3 h
for EST database search. The movement of data and inte-
gration of different search results was carried out using
several in-house developed programs.
The iterative database search strategy described here is
flexible, and different combinations of methods for reana-
lysis of unassigned high-quality spectra can be applied. It is
worth noting, however, that despite all efforts, a substantial
fraction of the high-quality spectra in the data set used in
this work remain unassigned. The success rate of peptide
identification can be further improved by using a combi-
nation of different search engines (in addition to X!
TANDEM and InsPecT used here) [35, 36], as well as by
implementing more accurate peptide fragmentation models
[37]. It has been suggested that a significant number of
unidentified spectra are chimera spectra resulting from co-
fragmentation of two or more different peptides [25, 32, 38].
Additional work is necessary to develop methods to analyze
MS/MS data allowing for the possibility of chimera spectra,
as well as to get a better understanding of the practical
importance of identifying such spectra for increasing the
total number of identified peptides and proteins. Other
computational strategies not relying on database searching
may also be required for further improving the sensitivity of
peptide identifications, e.g. de novo sequencing [39, 40]. It
should also be noted that given continuous improvements
in MS instrumentation, the strategy presented here will
need to be revised in the future. For example, in the case of
MS/MS spectra generated on high mass accuracy instru-
ments, substantial improvements can be achieved via more
accurate determination of the precursor ion charge state and
m/z [41].
The iterative approach utilized in this work could be of
general interest beyond the primary focus of this technical
brief on understanding the sources of unassigned high-
quality spectra. First, it can be used to more effectively
search for novel peptides (SNPs, novel splice variants) as
way to improve genome annotation [42, 43]. Second, the
method can assist in obtaining a more complete picture of
how the rates of various modifications (post-translational
and chemical), as well as numbers of semi-tryptic peptides
and peptides with missed cleavages, vary from sample to
sample and change as a function of experimental or sample
handling conditions. Such an analysis is particularly
important in the context of targeted proteomic studies using
multiple reaction monitoring assays, where accurate peptide
quantification requires normalization to account for peptide
modifications and changes in the efficiency of trypsin
digestion [44]. Finally, one may envision that iterative/
multistep data analysis strategies will play a more promi-
nent role in future proteomic studies. We note, however,
that routine application of iterative strategies such as the
one utilized in this work, especially in a high-throughput
environment, will require further substantial work on the
development of statistical FDR estimation methods applic-
able to a wide range of peptide identification approaches,
including subset database searching, blind PTM analysis,
and genomic searches.
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